Author | Davendra Sohal, MD, MPH | OncLive

Author | Davendra Sohal, MD, MPH

Articles

Dr. Sohal on Eligibility of Patients with Pancreatic Cancer for Clinical Trials

July 04, 2019

Video

Davendra Sohal, MD, MPH, discusses the SWOG S1505 trial, which looks at initial findings on eligibility and neoadjuvant chemotherapy experience with mFOLFIRINOX versus gemcitabine/nab-paclitaxel for resectable pancreatic adenocarcinoma.

Dr. Sohal on Perioperative mFOLFIRINOX in Pancreatic Adenocarcinoma

June 22, 2017

Video

Davendra Sohal, MD, MPH, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses an ongoing study exploring mFOLFIRINOX versus gemcitabine and nab-paclitaxel (Abraxane) in patients with resectable pancreatic adenocarcinoma.

Dr. Sohal on the Challenges of Standardizing Genomic Profiling and Precision Medicine

September 09, 2015

Video

Davendra Sohal, MD, MPH, oncologist and Director of the Clinical Genomics Program at the Cleveland Clinic Taussig Cancer Institute, discusses the feasibility of standardizing genomic profiling and apply precision medicine techniques.

x